Delivery Order SPE2DR25D3020-SPE2DR26F9P9C
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packaging) valued at $1,481.13, with a firm fixed price structure. This award, issued on November 25, 2025, represents a non-competitive delivery order with an ultimate completion date of November 26, 2025. The contract is performed out of AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of MULTAQ 400 mg tablets in a 60-count package, with a contract ceiling value of $6,017.84. This is a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, issued under a non-competitive, non-set-aside procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical...
- The Defense Logistics Agency awarded a $44,277.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60-count units) on November 6, 2025, with an ultimate completion date of November 7, 2025. This contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,481.13 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MULTAQ is a prescription antiarrhythmic medication used in the treatment...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60-count) valued at $1,740.27 under a firm fixed-price contract. The award was made on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the location of performance for this pharmaceutical supply order. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $2,247.47. The award, issued on May 23, 2025, with an ultimate completion date of May 27, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this delivery order, which supplies pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,477.84 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of MULTAQ 400 mg tablets (60-count packages). This firm fixed price delivery order, which must be completed by November 7, 2025, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency awarded a $4,824.44 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $1,529.88 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packages) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award was competitively procured with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $6,028.44 to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count packages) on November 28, 2025, with a completion date of December 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DR25D3020Indefinite Delivery Contract
- SPE2DR25D3020-SPE2DR26F9P9CDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,016.52 to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60-count units). The contract is a firm fixed price delivery order issued on December 11, 2025, with an ultimate completion date of December 12, 2025. This award is non-set-aside and was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. MULTAQ, an antiarrhythmic medication, represents one of the specialized pharmaceutical products available through this contract vehicle, which also encompasses brand-name and generic drugs, vaccines, and other critical medical commodities for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 12/10/25 |